Women’s health makes only 4% of the overall funding that goes into the research and development of healthcare products and services. Most of the spending on diseases is male-specific. Male-specific conditions such as prostate cancer account for around 2% of the overall funding. Today, women account for 49.6% of the total population across the world. The economic burden on women-specific diseases has reached over $500 billion. Healthcare should become personalized and patient-centric, which, in turn, increases the demand for management and delivery of healthcare to be genderneutral. For several decades, healthcare products and solutions were designed, developed, and delivered without much attention to the fact that healthcare needs are different for men and women, considering their physiological differences. There is an urgent need for building different products for women and find solutions that are specific to the physiology of women. As there are fundamental differences in the process of metabolizing drugs for women and men, inclusion of women in product development, clinical trials, research, and marketing has become essential. Currently, a wave of change has emerged in healthcare companies that are increasingly recognizing the need to serve women better.

1 RESEARCH METHODOLOGY 

2 RESEARCH OBJECTIVES 

3 RESEARCH PROCESS 

4 SCOPE & COVERAGE

5 REPORT ASSUMPTIONS & CAVEATS 

6 MARKET AT A GLANCE 

7 INTRODUCTION 

8 MARKET OPPORTUNITIES & TRENDS 

9 MARKET GROWTH ENABLERS 

10 MARKET RESTRAINTS

11 MARKET LANDSCAPE 

12 PRODUCT TYPE 

13 INDICATION